Literature DB >> 15081095

Linezolid-induced bradycardia: a case report.

Alfredo Tartarone1, Giuseppina Gallucci, Giovanni Iodice, Giampiero Romano, Mariarosa Coccaro, Maria Luigia Vigliotti, Giuseppe Mele, Rosella Matera, Nicola Di Renzo.   

Abstract

We report an episode of severe bradycardia that occurred in a 49-year-old woman with fever and malignant jaundice during antibiotic therapy with linezolid, a new oxazolidinone with activity against Gram-positive cocci. In our case, the strict temporal dependence between bradycardia and linezolid therapy seems to provide strong evidence for a causal relationship. To our knowledge, this is the first report of linezolid-induced bradycardia. This adverse event confirms that the new antibiotic linezolid should be administered with caution in patient with jaundice and hepatic insufficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081095     DOI: 10.1016/j.ijantimicag.2003.10.001

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.

Authors:  Gabriela Grunder; Yvonne Zysset-Aschmann; Florence Vollenweider; Thomas Maier; Stephan Krähenbühl; Juergen Drewe
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Staphylococcal meningitis therapy with linezolid in a young infant: efficacy, CSF levels and side effects.

Authors:  Cinzia Auriti; Fiammetta Piersigilli; Iliana Bersani; Sara Cairoli; Paolina Giuseppina Amante; Daniela Longo; Bianca Maria Goffredo
Journal:  Ital J Pediatr       Date:  2020-06-29       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.